EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Flavonoid Oxime Carbamate Derivatives: Reversal of Multidrug Resistance in Cancer Cells

Filipa Barbosa, Gabriella Spengler, Noémi Bózsity, Nikoletta Szemerédi, István Zupkó, Maria-José U Ferreira iD

ChemMedChem · 14.04.2026 · 21 (7)

DOI: 10.1002/cmdc.202501113 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 16.04.2026. Verfasst von Filipa Barbosa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal. Hauptthemen laut MEDLINE: Oximes, Drug Resistance, Neoplasm, Drug Resistance, Multiple, Carbamates. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundação para a Ciência e aTecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The effectiveness of cancer treatment has been seriously hindered by the development of multidrug resistance (MDR), mainly mediated by efflux transporters such as P‐glycoprotein (P‐gp/ABCB1). Aiming at obtaining new compounds for overcoming MDR in cancer, tangeretin ( 1 ), a natural polymethoxyflavonoid, was derivatized. After obtaining the corresponding oxime ( 2 ), a set of 23 novel oxime carbamates ( 3 – 26 ) was prepared via carbonyldiimidazole‐mediated reaction with various amines or by reaction with isocyanates. Their structures were assigned mainly by 1D and 2D NMR experiments. The compounds ( 1–26 ) were evaluated for their MDR reversal potential, using the rhodamine‐123 accumulation assay and chemosensitivity experiments, in human ABCB1 ‐gene transfected L5178Y mouse lymphoma cells. A significant increase in P‐gp inhibitory activity was observed for most of the derivatives at noncytotoxic concentrations. Notably, compounds 19 , 20 , and 22 , bearing an aliphatic substituent, were the most active, exhibiting a strong MDR reversal effect at 2 μM. Moreover, drug combination assays revealed that most of the derivatives were able to synergize doxorubicin. Selected compounds were also tested in the ATPase assay, where most of them acted as inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OximesDrug Resistance, NeoplasmDrug Resistance, MultipleCarbamatesAntineoplastic AgentsFlavonoidsHumansAnimalsMiceStructure-Activity RelationshipCell Line, TumorMolecular StructureATP Binding Cassette Transporter, Subfamily BDrug Screening Assays, AntitumorDose-Response Relationship, Drug

Stichwörter der Autor:innen

P‐glycoproteinmultidrug resistanceoxime carbamatepolymethoxyflavonoidtangeretin

Substanzen

OximesCarbamatesAntineoplastic AgentsFlavonoidsATP Binding Cassette Transporter, Subfamily B

Autor:innen und Institutionen

  • Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.
  • Department of Medical Microbiology, Albert Szent-Györgyi Health Center, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
  • Institute of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, Szeged, Hungary.

ORCID-Profile: Maria-José U Ferreira

Förderung

  • Fundação para a Ciência e aTecnologia

Zitieren

APA

Barbosa, F., Spengler, G., Bózsity, N., Szemerédi, N., Zupkó, I., & Ferreira, M. U. (2026). Flavonoid Oxime Carbamate Derivatives: Reversal of Multidrug Resistance in Cancer Cells. ChemMedChem, 21(7). https://doi.org/10.1002/cmdc.202501113

Vancouver

Barbosa F, Spengler G, Bózsity N, Szemerédi N, Zupkó I, Ferreira MU. Flavonoid Oxime Carbamate Derivatives: Reversal of Multidrug Resistance in Cancer Cells. ChemMedChem. 2026;21(7). doi:10.1002/cmdc.202501113

BibTeX
@article{Barbosa2026,
  author = {Barbosa, Filipa and Spengler, Gabriella and Bózsity, Noémi and Szemerédi, Nikoletta and Zupkó, István and Ferreira, Maria-José U},
  title = {Flavonoid Oxime Carbamate Derivatives: Reversal of Multidrug Resistance in Cancer Cells},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {7},
  doi = {10.1002/cmdc.202501113}
}
Kostenlos starten →